直接子宫肌瘤热消融术后的妊娠结局:文献综述
本文综述了射频容积热消融(RFVTA)或磁共振引导高强度聚焦超声(MRgHIFU)治疗肌瘤后女性的生殖结局。RFVTA后报告20例妊娠,其中12例活产足月分娩(剖宫产9例,阴道分娩3例);MRgHIFU后报告102例妊娠,48例分娩,1例因前置胎盘36周早产。作者认为需进一步研究这些肌瘤治疗后的生殖结局。
要点
- RFVTA后20例妊娠中12例活产足月分娩,剖宫产9例(75%),阴道分娩3例(25%)。
- MRgHIFU后102例妊娠中48例分娩,1例因前置胎盘36周早产,无子宫破裂报告。
- RFVTA和MRgHIFU是治疗肌瘤的新型微创替代方案,其生殖结局需进一步研究。
核心结论
- RFVTA和MRgHIFU是治疗肌瘤的新型微创替代方案。
- 进一步研究这些肌瘤治疗后的生殖结局对于确定其是否是有症状肌瘤且希望未来生育女性的适当治疗选择至关重要。
研究设计与样本
- 本文为文献综述,纳入全球多个学术和私人中心关于直接肌瘤热消融后生殖结局的现有病例报告。
- 通过PubMed和Medline进行文献检索,纳入所有包含接受射频肌瘤消融或MRgHIFU后妊娠女性数据的出版物。
主要发现
- 直接子宫肌瘤热消融后共有122例妊娠,其中RFVTA后报告20例妊娠。
- RFVTA后20例妊娠中,1例自然流产,7例选择性终止,剩余12例活产足月分娩,9例(75%)剖宫产,3例(25%)阴道分娩;分娩时无子宫异常报告,1例延迟性产后出血伴变性肌瘤排出。
- MRgHIFU后报告102例妊娠,其中21例自然流产,22例选择性终止,48例分娩,报告时11例持续妊娠。
- MRgHIFU后1例因前置胎盘36周早产,其余分娩为足月;报告的并发症包括阴道点滴出血(12.5%)、延迟性胎盘剥离(4%)和前置胎盘(4%);无子宫破裂病例。
局限性
- 进一步研究这些肌瘤治疗后的生殖结局至关重要,以确定其是否是有症状肌瘤且希望未来生育女性的适当治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of this review is to describe the reproductive outcomes of women after radiofrequency volumetric thermal ablation (RFVTA) of myomas or magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU). This is a literature review of the current case reports of reproductive outcomes after direct myoma thermal ablation at multiple academic and private centers throughout the world. A literature search was performed using PubMed and Medline. All publications that included data of women who underwent radiofrequency myoma ablation or MRgHIFU of myomas and subsequently conceived were included. There were 122 pregnancies after direct uterine myoma thermal ablation, and 20 pregnancies were reported after RFVTA. Of these cases, there was 1 spontaneous abortion and 7 elective terminations. The remaining 12 pregnancies went on to have live full-term deliveries, 9 (75%) by cesarean section and 3 (25%) by vaginal delivery. There were no reports of uterine abnormalities at delivery and 1 delayed postpartum hemorrhage with expulsion of a degenerated myoma. There are 102 reported pregnancies after MRgHIFU. There were 21 spontaneous abortions and 22 elective terminations, 48 deliveries, and 11 ongoing pregnancies at the time of report. There was 1 preterm delivery at 36 weeks due to placenta previa, and the remaining deliveries were full term. The complications reported included vaginal spotting (12.5%), delayed placental separation (4%), and placenta previa (4%). There were no cases of uterine rupture. In summary, RFVTA and MRgHIFU are new minimally invasive alternatives for the treatment of myomas. Further investigation into the reproductive outcomes after these myoma therapies is crucial to determine whether these are appropriate treatment options for women with symptomatic myomas who desire future fertility.
引用
- Keltz J, Levie M, Chudnoff S, et al. Pregnancy Outcomes After Direct Uterine Myoma Thermal Ablation: Review of the Literature. J Minim Invasive Gynecol. 2017. PMID: 28109894. doi:10.1016/j.jmig.2017.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。